Restricted Versus Liberal Fluid Intake for Prevention of Bronchopulmonary Dysplasia
NCT06954142 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 750
Last updated 2026-05-08
Summary
The aim of this study is to determine whether restricted fluid intake (135 ±5 mL/kg/day) compared to liberal fluid intake (165 ±5 mL/kg/day) from day 8 of life reduces the incidence of bronchopulmonary dysplasia (BPD) at 36 weeks postmenstrual age or prior death in preterm infants born \<30 weeks gestational age.
Conditions
- Bronchopulmonary Dysplasia
Interventions
- OTHER
-
Fluid restriction
Fluid restriction strategy (fluid target 135 ±5 mL/kg/d)
- OTHER
-
Liberal fluid intake
Liberal fluid intake strategy (fluid target 165 ± 5 mL/kg/d)
Sponsors & Collaborators
-
Swiss Neonatal Network
collaborator NETWORK -
SwissPedNet - Swiss Research Network of Clinical Pediatric Hubs
collaborator UNKNOWN -
University Children's Hospital Basel
lead OTHER
Principal Investigators
-
Sven Schulzke, Prof.MD · University Children's Hospital Basel
Study Design
- Allocation
- RANDOMIZED
- Purpose
- SUPPORTIVE_CARE
- Masking
- NONE
- Model
- CROSSOVER
Eligibility
- Min Age
- 8 Days
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2025-07-12
- Primary Completion
- 2029-12-31
- Completion
- 2029-12-31
Countries
- Switzerland
Study Locations
More Related Trials
-
L-citrulline and Pulmonary Hypertension Associated With Bronchopulmonary Dysplasia
NCT03542812 ·Status: TERMINATED ·Phase: EARLY_PHASE1
-
Physiologic Definition of Bronchopulmonary Dysplasia
NCT01223287 ·Status: COMPLETED
-
Surfactant Versus Nasal Continuous Positive Airway Pressure (nCPAP) for Respiratory Distress Syndrome in the Newborn ≥ 35 Weeks of Gestation
NCT01306240 ·Status: TERMINATED ·Phase: PHASE3
-
Impact of Steroid, Diuretic, and Fluid Use on BPD Outcomes
NCT04971694 ·Status: COMPLETED
-
Hydrocortisone for BPD
NCT01353313 ·Status: COMPLETED ·Phase: PHASE3
-
Duodenal Feeds in Very Low Birth Weight Infants
NCT04246333 ·Status: COMPLETED ·Phase: NA
-
Prospective Study on Plasma Pro-endothelin-1 in Predicting Bronchopulmonary Dysplasia
NCT01644981 ·Status: COMPLETED
-
Feasibility and Impact of Volume Targeted Ventilation in the Delivery Room
NCT03938532 ·Status: TERMINATED ·Phase: NA
-
Impact of Extended CPAP on Bronchopulmonary Dysplasia
NCT05547139 ·Status: COMPLETED ·Phase: NA
-
Transpyloric Versus Gastric Feeding in Bronchopulmonary Dysplasia
NCT06534359 ·Status: RECRUITING ·Phase: NA
-
Safety of Furosemide in Premature Infants at Risk of Bronchopulmonary Dysplasia (BPD)
NCT02527798 ·Status: COMPLETED ·Phase: PHASE2
-
Early NCPAP Before Surfactant Treatment in Very Preterm Infants With RDS
NCT01996670 ·Status: COMPLETED
-
Determining the Effect of Spironolactone on Electrolyte Supplementation in Preterm Infants With Chronic Lung Disease
NCT01721655 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Sustained Lung Inflation With CPAP in Preterm Neonates (SI-CPAP)
NCT03916523 ·Status: COMPLETED ·Phase: NA
-
Early Versus Late Caffeine for ELBW Newborns
NCT02524249 ·Status: TERMINATED ·Phase: NA
-
Ultrasound Assessment of Diaphragmatic Function in Infants With BPD
NCT04941963 ·Status: COMPLETED
-
The Effect of Surfactant Dose on Outcomes in Preterm Infants With RDS
NCT03808402 ·Status: COMPLETED
-
PREMILOC Trial to Prevent Bronchopulmonary Dysplasia in Very Preterm Neonates
NCT00623740 ·Status: COMPLETED ·Phase: PHASE3
-
Optimal Dose of Surfactant for Preterm Infants With Respiratory Distress Syndrome
NCT04984057 ·Status: UNKNOWN ·Phase: NA
-
Risk Factors in Bronchopulmonary Dysplasia (Newborn Lung Project)
NCT00005289 ·Status: COMPLETED
-
Benchmarking Initiative to Reduce Bronchopulmonary Dysplasia
NCT00067613 ·Status: COMPLETED ·Phase: NA
-
Surfactant for Neonatal Respiratory Distress Syndrome(NRDS) and Neonatal Acute Respiratory Distress Syndrome(NARDS)
NCT04777760 ·Status: RECRUITING
-
Impact of Prepartum Intravenous Fluid Intake on Newborn Weight Loss in the First Days of Life
NCT07243054 ·Status: RECRUITING
-
Corticosteroid Use in Premature Babies and Lung Ultrasonografi Use in the Progression to Bronchopulmonary Dysplasia
NCT05621785 ·Status: UNKNOWN
-
Management of Apnea in Late Preterm and Term Infants
NCT02408328 ·Status: WITHDRAWN ·Phase: PHASE2